Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss caused by genetics and hormones; more research needed for treatments.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Current treatments for alopecia show no significant long-term benefits.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Some chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.